Lange Clinical Neurology, 11th Edition

<p>Chapter 1. NeurologicHistory & Examination</p><p>Neurologic examination ofsphincter function</p><p>Chapter 2. InvestigativeStudies</p><p>Neuromuscular imaging studies</p><p>Update on ultrasonography forneuromuscular diagnosis</p><p>Chapter 3. Coma</p><p>Introduction</p><p>Role of prefrontal cortex in consciousness</p><p>Causes of coma</p><p>Spontaneous intracranialhypotension as a cause of coma</p><p>Persistent vegetative state</p><p>New imaging insights intopersistent vegetative & minimally conscious states</p><p>Treatment of traumatic vegetative &minimally conscious states with amantadine</p><p>Chapter 4. ConfusionalStates</p><p>Drugs</p><p>Serotonin syndrome</p><p>Electrolyte disorders</p><p>Antidepressant-inducedhyponatremia</p><p>Endocrine & metabolic disorders</p><p>Mechanisms of impairedhypoglycemia sensing in treated diabetes</p><p>Nutritional disorders</p><p>Furosemide-induced thiaminedeficiency</p><p>Organ system failure</p><p>ICU delirium</p><p>Postoperative cognitivedysfunction</p><p>Meningitis, encephalitis & sepsis</p><p>Mechanism of N. meningitidis vascular spread</p><p>Dysregulated host inflammatoryresponse in tuberculous meningitis</p><p>CSF findings in HIV-infectedpatients with tuberculous meningitis</p><p>Tick-borne encephalitis & (re-emergent)yellow fever</p><p>Nipah virus encephalitis</p><p>Updated diagnostic testing forviral encephalitis</p><p>New recommendation on empiricaltreatment of toxoplasmosis in AIDS</p><p>Fexinidazole for treatment of Africantrypanosomiasis </p><p>Mechanism of meningeal invasion inleukemia</p><p>Chapter 5. Dementia& Amnestic Disorders</p><p><span>Introduction</span></p><p><span>Somatic neuronal mutations in aging and neurodegeneration</span></p><p><span>Differential diagnosis</span></p><p><span>Biomarker-based diagnostic algorithms for dementia syndromes</span></p><p><span>Neurodegenerativeproteinopathies</span></p><p>Tau folding in Alzheimer vs. Pickdisease</p><p>Tau-disrupted nucleocytoplasmictransport in Alzheimer disease pathogenesis</p><p>Contrasting mechanisms ofaggregate toxicity in neurodegeneration</p><p>Herpes simplex virus infection andAlzheimer disease</p><p>Inflammation in Alzheimer diseasepathogenesis</p><p>Meningeal lymphatics (glymphatics)in Alzheimer disease pathogenesis</p><p>Blood pressure and risk of Alzheimerdisease</p><p>Relation between epilepsy anddementia</p><p>Exercise training in dementia</p><p>Sex differences in Alzheimerdisease</p><p>Spatial navigation deficits asearly signs of Alzheimer disease</p><p>Subjective cognitive decline in relationto Alzheimer disease</p><p>Update on biomarkers for Alzheimerdisease</p><p>Concomitant neurodegenerativeproteinopathies</p><p>Update on clinical trials oftreatments for Alzheimer disease (eg, solanezumab, verubecestat)</p><p>Clinical and pathologicalcorrelates of primary progressive aphasia variants</p><p>New consensus guidelines fordiagnosis & treatment of dementia with Lewy bodies</p><p>Skin prions in Creutzfeldt-Jakobdisease infectivity and diagnosis</p><p>Other cerebral disorders</p><p><span>Shunting response to gait vs. dementia in normal pressurehydrocephalus</span></p><p>Normal pressure hydrocephalus vs.neurodegenerative ventriculomegaly</p><p>Mild traumatic brain injury & dementia</p><p>Systemic disorders</p><p>Subclinical hyperthyroidism &dementia</p><p>Pseudodementia</p><p>Features of memory impairment in depression</p><p>Amnestic syndromes</p><p>Update on antibody-mediatedencephalitis antigens & treatment</p><p>Chapter 6. Headache& Facial Pain</p><p>Migraine</p><p>Triptans, SSRIs & serotoninsyndrome</p><p>CGRP receptor-blocking monoclonalantibodies (eg, erenumab, fremanezumab)</p><p>Prochlorperazine plusdiphenhydramine vs. hydromorphone for IV migraine therapy</p><p>Vagus nerve